Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ACADIA Pharmaceuticals (GB:0A4W)
LSE:0A4W
RESEARCH TOOLSreports
ACADIA Pharmaceuticals (0A4W) Ownership - Who Owns ACADIA Pharmaceuticals?
0 Followers
ACADIA Pharmaceuticals (0A4W) Ownership Overview
51.75% Insiders
19.06% Mutual Funds
17.58% Other Institutional Investors
11.60% Public Companies and
Individual Investors
The ownership structure of ACADIA Pharmaceuticals (GB:0A4W) stock is a mix of institutional, retail and individual investors. Approximately 36.65% of the company’s stock is owned by Institutional Investors, 51.75% is owned by Insiders and 11.60% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 09, 2024 | Stephen Davis Ceo,director | Sold | $111811 |
| Oct 06, 2023 | Stephen Davis Ceo,director | Sold | $1132323 |
| Oct 06, 2023 | Austin D. Kim Evp,general Counsel, Secretary | Sold | $359463 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $178748 | |
| Dec 31, 2023 | Bought | $292122 | |
| Dec 31, 2023 | Bought | $304583 | |
| Dec 31, 2023 | Bought | $3162310 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 42,864,612 | Institution | 26.01% | 702,765,314 | |
| 39,536,729 | Insider | 23.99% | 648,204,672 | |
| 11,621,421 | Institution | 7.05% | 190,533,197 | |
| 10,493,355 | Institution | 6.37% | 172,038,555 | |
| 5,964,129 | Institution | 3.62% | 97,781,895 | |
| 3,347,837 | Institution | 2.03% | 54,887,788 | |
| 2,407,888 | Institution | 1.46% | 39,477,324 | |
| 2,270,873 | Institution | 1.38% | 37,230,963 | |
| 2,131,525 | Institution | 1.29% | 34,946,352 | |
| 1,705,113 | Institution | 1.03% | 27,955,328 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,493,355 | Institution | 6.37% | 172,038,555 | |
| 2,407,888 | Institution | 1.46% | 39,477,324 | |
| 1,705,113 | Institution | 1.03% | 27,955,328 | |
| 1,294,295 | Institution | 0.79% | 21,219,967 | |
| 1,228,741 | Institution | 0.75% | 20,145,209 | |
| 1,195,370 | Institution | 0.73% | 19,598,091 | |
| 1,006,405 | Institution | 0.61% | 16,500,010 | |
| 835,391 | Institution | 0.51% | 13,696,235 | |
| 758,178 | Institution | 0.46% | 12,430,328 | |
| 729,863 | Institution | 0.44% | 11,966,104 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns ACADIA Pharmaceuticals (GB:0A4W)?
According to the latest TipRanks data, approximately 17.58% of the company's stock is held by institutional investors, 51.75% is held by insiders, and 11.60% is held by retail investors.
What percentage of ACADIA Pharmaceuticals (GB:0A4W) stock is held by institutional investors?
According to the latest TipRanks data, approximately 17.58% of ACADIA Pharmaceuticals (GB:0A4W) stock is held by institutional investors.
What percentage of ACADIA Pharmaceuticals (GB:0A4W) stock is held by retail investors?
According to the latest TipRanks data, approximately 11.60% of ACADIA Pharmaceuticals (GB:0A4W) stock is held by retail investors.
Who owns the most shares of ACADIA Pharmaceuticals (GB:0A4W)?
Felix Baker owns the most shares of ACADIA Pharmaceuticals (GB:0A4W).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.